These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development. Vancamp P; Darras VM Gen Comp Endocrinol; 2018 Sep; 265():219-229. PubMed ID: 29183795 [TBL] [Abstract][Full Text] [Related]
7. Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. Wirth EK; Roth S; Blechschmidt C; Hölter SM; Becker L; Racz I; Zimmer A; Klopstock T; Gailus-Durner V; Fuchs H; Wurst W; Naumann T; Bräuer A; de Angelis MH; Köhrle J; Grüters A; Schweizer U J Neurosci; 2009 Jul; 29(30):9439-49. PubMed ID: 19641107 [TBL] [Abstract][Full Text] [Related]
8. Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139 [No Abstract] [Full Text] [Related]
9. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients. Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548 [TBL] [Abstract][Full Text] [Related]
10. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome. Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950 [TBL] [Abstract][Full Text] [Related]
11. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency. Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867 [No Abstract] [Full Text] [Related]
12. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation. Armour CM; Kersseboom S; Yoon G; Visser TJ PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690 [TBL] [Abstract][Full Text] [Related]
13. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination. Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262 [TBL] [Abstract][Full Text] [Related]
14. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution. Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058 [TBL] [Abstract][Full Text] [Related]
15. Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation. Zada D; Tovin A; Lerer-Goldshtein T; Vatine GD; Appelbaum L PLoS Genet; 2014 Sep; 10(9):e1004615. PubMed ID: 25255244 [TBL] [Abstract][Full Text] [Related]